“ACALABRUTINIB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA”, RECIMA21, vol. 4, no. 6, p. e463311, Jun. 2023, doi: 10.47820/recima21.v4i6.3311.